{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:50:36Z","timestamp":1789537836473,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004061","name":"Austrian National Bank","doi-asserted-by":"publisher","award":["14621"],"award-info":[{"award-number":["14621"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Society for Bone and Mineral Research"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bone.2017.08.030","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T06:31:24Z","timestamp":1505370684000},"page":"212-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism \u2013 The randomized, placebo-controlled EPATH trial"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-4056","authenticated-orcid":false,"given":"Nicolas","family":"Verheyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Gr\u00fcbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meinitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Schwetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Amrein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans P.","family":"Dimai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"von Lewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Voelkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Alesutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Fahrleitner-Pammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Brussee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Tomaschitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2017.08.030_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.bone.2017.08.030_bb0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bone.2017.08.030_bb0015","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/HYPERTENSIONAHA.114.01997","article-title":"Endothelial cell mineralocorticoid receptors: turning cardiovascular risk factors into cardiovascular dysfunction","volume":"63","author":"Jaffe","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.bone.2017.08.030_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.bone.2017.08.030_bb0025","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","article-title":"Colocalization of glucocorticoid and mineralocorticoid receptors in human bone","volume":"16","author":"Beavan","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.08.030_bb0030","doi-asserted-by":"crossref","first-page":"C1088","DOI":"10.1152\/ajpcell.1996.270.4.C1088","article-title":"Evidence for receptor-mediated mineralocorticoid action in rat osteoblastic cells","volume":"270","author":"Agarwal","year":"1996","journal-title":"Am. J. Phys."},{"issue":"3","key":"10.1016\/j.bone.2017.08.030_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","article-title":"Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia","volume":"447","author":"Fumoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2017.08.030_bb0040","doi-asserted-by":"crossref","first-page":"H286","DOI":"10.1152\/ajpheart.00535.2005","article-title":"Calcium paradox of aldosteronism and the role of the parathyroid glands","volume":"290","author":"Vidal","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.bone.2017.08.030_bb0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","article-title":"Hyperparathyroidism and the calcium paradox of aldosteronism","volume":"111","author":"Chhokar","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bone.2017.08.030_bb0050","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2016-3206","article-title":"Primary aldosteronism as a risk factor for vertebral fracture","volume":"102","author":"Notsu","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2017.08.030_bb0055","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess","volume":"24","author":"Ceccoli","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.08.030_bb0060","doi-asserted-by":"crossref","first-page":"836529","DOI":"10.1155\/2014\/836529","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","author":"Petramala","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bone.2017.08.030_bb0065","article-title":"Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism","author":"Loh","year":"2016","journal-title":"Minerva Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2017.08.030_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","article-title":"Fracture risk in men with congestive heart failure risk reduction with spironolactone","volume":"52","author":"Carbone","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bone.2017.08.030_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6823-12-19","article-title":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Tomaschitz","year":"2012","journal-title":"BMC Endocr. Disord."},{"issue":"7","key":"10.1016\/j.bone.2017.08.030_bb0080","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/HJH.0000000000000927","article-title":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial","volume":"34","author":"Tomaschitz","year":"2016","journal-title":"J. Hypertens."},{"issue":"7","key":"10.1016\/j.bone.2017.08.030_bb0085","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2012-1156","article-title":"Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study","volume":"97","author":"Vaidya","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2017.08.030_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","article-title":"Primary hyperparathyroidism with concurrent primary aldosteronism","volume":"58","author":"Maniero","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.bone.2017.08.030_bb0095","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1210\/jc.2014-3949","article-title":"Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis","volume":"100","author":"Brown","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.08.030_bb0100","doi-asserted-by":"crossref","first-page":"4138783","DOI":"10.1155\/2017\/4138783","article-title":"Angiotensin-converting enzyme inhibition and parathyroid hormone secretion","volume":"2017","author":"Zaheer","year":"2017","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2017.08.030_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","article-title":"Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease","volume":"94","author":"Tomaschitz","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.bone.2017.08.030_bb0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","article-title":"Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease","volume":"63","author":"Tomaschitz","year":"2014","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.bone.2017.08.030_bb0115","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0000000000001004","article-title":"Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial","volume":"34","author":"Verheyen","year":"2016","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.bone.2017.08.030_bb0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/jhh.2010.110","article-title":"Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension","volume":"25","author":"Vaidya","year":"2011","journal-title":"J. Hum. Hypertens."},{"issue":"4","key":"10.1016\/j.bone.2017.08.030_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173799","article-title":"Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: the EPATH trial","volume":"12","author":"Verheyen","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bone.2017.08.030_bb0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am. J. Hypertens."},{"issue":"5","key":"10.1016\/j.bone.2017.08.030_bb0135","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T06:07:47Z","timestamp":1539151667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217303253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":27,"alternative-id":["S8756328217303253"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.08.030","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism \u2013 The randomized, placebo-controlled EPATH trial","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}